by
Uğur, Deniz, author.
Format:
El Yazması
Alıntı:
Cancer cells -- Proliferation.
by
Alkan, Ayşe Hale, author.
Format:
El Yazması
Alıntı:
one comparison of cell lines. TNFRSF10B-AS silencing decreased proliferation of HeLa cells. lncCAMTA1
View Other Search Results
by
Can, Ali, author.
Format:
El Yazması
Alıntı:
breast cancer cells and normal mammary epithelial cells. To achieve this goal, we aim to: 1. Optimize the
by
Akyıldız Demir, Seçil, author.
Format:
El Yazması
Alıntı:
cancer metabolism, neuronal differentiation and myoblast differentiation, proliferation and hypertrophy
by
Bozoğlu, Hülya, author.
Format:
El Yazması
Alıntı:
of cancer cells. New drugs that inhibit this interaction are important for the treatment of cancer
by
Gürler, Sevim Beyza, author.
Format:
El Yazması
Alıntı:
thatluteolin has anti-cancer and anti-tumor effects on wide range cancer types including breast, colon, lung
by
Olçum Uzan, Melis, author.
Format:
El Yazması
Alıntı:
slowed proliferation. Non-aggressive breast cancer has not responded to LMMS. In mammary epithelial cells
by
Çetinkaya, Melisa, author.
Format:
El Yazması
Alıntı:
cells alongside with the cancer cells. Therefore, there is a need to identify nontoxic, costeffective
by
Yöndem, Eyüp, author.
Format:
El Yazması
Alıntı:
cancer-related deaths in women. Breast tumor mass is not only harboring cancer cells but also several types of
by
Sağlam, Ezgi İrem, author.
Format:
El Yazması
Alıntı:
. Fucoidan strongly binds to P-selectins overexpressed in the breast cancer cells, blocking the cancer cells
by
Gürer, Dilek Cansu, author.
Format:
El Yazması
Alıntı:
cellular processes. To determine which ones are related to cell proliferation and apoptosis in HeLa cells
by
Günyüz, Zehra Elif, author.
Format:
El Yazması
Alıntı:
proliferation and an increase in migration. On the other hand, in the MDA-MB-231 breast cancer cell line
Arama Sonuçlarını Sınırlandır